(Q69773109)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2803458%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

title

The minimum inhibitory concentrations of various bismuth salts against Campylobacter pylori (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2803458%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference

Campylobacter pylori

1 reference

Vogt K

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2803458%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

Warrelmann M

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2803458%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

Hahn H

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2803458%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

publication date

1 September 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2803458%20AND%20SRC:MED&resulttype=core&format=json

Zentralblatt fur Bakteriologie : international journal of medical microbiology

5 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2803458%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

volume

271

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2803458%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2803458%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

page(s)

304-310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2803458%20AND%20SRC:MED&resulttype=core&format=json

Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro--an ultrastructural study

5 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2889%2980028-3

7 January 2021

The role of colloidal bismuth subcitrate in the short-term treatment of duodenal ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2889%2980028-3

7 January 2021

Acid, pepsin, and mucus secretion in patients with gastric and duodenal ulcer before and after colloidal bismuth subcitrate (De-Nol).

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2889%2980028-3

7 January 2021

Ultrastructure of the gastric mucosa harboring Campylobacter-like organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2889%2980028-3

7 January 2021

Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2889%2980028-3

7 January 2021

Recent experimental and clinical studies on the pharmacology of colloidal bismuth subcitrate

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2889%2980028-3

7 January 2021

DOUBLE-BLIND TRIAL OF BISMUTH ALUMINATE AND MAGNESIUM TRISILICATE IN PEPTIC ULCERATION WITH SIMULTANEOUS GASTRIC ANALYSIS.

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2889%2980028-3

7 January 2021

Campylobacter pyloridis, gastritis, and peptic ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2889%2980028-3

7 January 2021

The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis.

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2889%2980028-3

7 January 2021

Protective properties of colloidal bismuth subcitrate on gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2889%2980028-3

7 January 2021

Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2889%2980028-3

7 January 2021

Comparison of tri-potassium di-citrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2889%2980028-3

7 January 2021

Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2889%2980028-3

7 January 2021

Relapse of duodenal ulcer: does it matter which drug is used in initial treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2889%2980028-3

7 January 2021

Colloidal bismuth subcitrate and ranitidine in the short-term treatment of benign gastric ulcer. An endoscopically controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2889%2980028-3

7 January 2021

Evaluation of colloidal bismuth (De-Nol) in the treatment of duodenal ulcer employing endoscopic selection and follow up.

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2889%2980028-3

7 January 2021

In vitro synergistic activity between bismuth subcitrate and various antimicrobial agents against Campylobacter pyloridis (C. pylori)

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2889%2980028-3

7 January 2021

10.1016/S0934-8840(89)80028-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2803458%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference